137 related articles for article (PubMed ID: 34571584)
21. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
22. RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.
Liu T; Zhang J; Zhang J; Mu X; Su H; Hu X; Liu W; Zhao E; Li W
PLoS One; 2013; 8(4):e60414. PubMed ID: 23577108
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
Cho JW; Il KJ; Lee KS
Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
[TBL] [Abstract][Full Text] [Related]
24. Heat Shock Protein 90 Inhibitor Decreases Collagen Synthesis of Keloid Fibroblasts and Attenuates the Extracellular Matrix on the Keloid Spheroid Model.
Lee WJ; Lee JH; Ahn HM; Song SY; Kim YO; Lew DH; Yun CO
Plast Reconstr Surg; 2015 Sep; 136(3):328e-337e. PubMed ID: 26313837
[TBL] [Abstract][Full Text] [Related]
25. TGF-β1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21.
Liu Y; Li Y; Li N; Teng W; Wang M; Zhang Y; Xiao Z
Sci Rep; 2016 Aug; 6():32231. PubMed ID: 27554193
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and possible mechanisms of Botulinum Toxin type A on hypertrophic scarring.
Hao R; Li Z; Chen X; Ye W
J Cosmet Dermatol; 2018 Jun; 17(3):340-346. PubMed ID: 29569821
[TBL] [Abstract][Full Text] [Related]
27. Myofibroblasts Are Not Characteristic Features of Keloid Lesions.
Hahn JM; McFarland KL; Combs KA; Powell HM; Supp DM
Plast Reconstr Surg Glob Open; 2022 Nov; 10(11):e4680. PubMed ID: 36448015
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of fibronectin extra domain B suppresses TGF-β1-mediated cell proliferation and collagen deposition in keloid fibroblasts via AKT/ERK signaling pathway.
Cui J; Li Z; Jin C; Jin Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1131-1137. PubMed ID: 32317186
[TBL] [Abstract][Full Text] [Related]
29. [Effects of hypoxia on the phenotype transformation of human dermal fibroblasts to myofibroblasts and the mechanism].
Zhao B; Han F; Zhang W; Wang XJ; Zhang J; Yang FF; Shi JH; Su LL; Hu DH
Zhonghua Shao Shang Za Zhi; 2017 Jun; 33(6):368-373. PubMed ID: 28648041
[No Abstract] [Full Text] [Related]
30. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
Liu JQ; Hu DH; Zhang ZF; Guan H; She T; Zhang J; Bai XZ
Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171
[TBL] [Abstract][Full Text] [Related]
31. Exclusive expression of KANK4 promotes myofibroblast mobility in keloid tissues.
Oishi M; Shinjo K; Takanari K; Muraoka A; Suzuki MM; Kanbe M; Higuchi S; Ebisawa K; Hashikawa K; Kamei Y; Kondo Y
Sci Rep; 2024 Apr; 14(1):8725. PubMed ID: 38622256
[TBL] [Abstract][Full Text] [Related]
32. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
33. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway.
Shi CK; Zhao YP; Ge P; Huang GB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9085-9092. PubMed ID: 31696499
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin type A versus 5-Fluorouracil in treatment of keloid.
Ismail SA; Mohammed NHK; Sotohy M; Abou-Taleb DAE
Arch Dermatol Res; 2021 Sep; 313(7):549-556. PubMed ID: 32892246
[TBL] [Abstract][Full Text] [Related]
36. Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases.
Macarak EJ; Wermuth PJ; Rosenbloom J; Uitto J
Exp Dermatol; 2021 Jan; 30(1):132-145. PubMed ID: 33211348
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-α inhibits transforming growth factor-β-stimulated myofibroblastic differentiation and extracellular matrix production in human gingival fibroblasts.
Arancibia R; Oyarzún A; Silva D; Tobar N; Martínez J; Smith PC
J Periodontol; 2013 May; 84(5):683-93. PubMed ID: 22813343
[TBL] [Abstract][Full Text] [Related]
38. Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway.
Hu J; Chen Y; Huang Y; Su Y
Exp Mol Pathol; 2020 Aug; 115():104468. PubMed ID: 32445750
[TBL] [Abstract][Full Text] [Related]
39. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
[TBL] [Abstract][Full Text] [Related]
40. Substrate stiffness influences TGF-β1-induced differentiation of bronchial fibroblasts into myofibroblasts in airway remodeling.
Shi Y; Dong Y; Duan Y; Jiang X; Chen C; Deng L
Mol Med Rep; 2013 Feb; 7(2):419-24. PubMed ID: 23229284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
